Table 5.
Drugs interacting with GI-lncRNAs using the ncRNADrug database.
| GI-lncRNA | Drug | DrugBank Accession Number | Cancer Type | PMID | FDA |
|---|---|---|---|---|---|
| KCNMB2-AS1 | Panobinostat | DB06603 | Nephroblastoma | 26176219 | approved |
| MIR9-1HG | Panobinostat | DB06603 | Nephroblastoma | 26176219 | approved |
| MIR9-1HG | Tetraarsenic Oxide | NA | Breast Cancer | 33932728 | NA |
| ELFN1-AS1 | Dexamethasone | DB01234 | Hepatocellular Carcinoma | 29409992 | approved |
| DLX6-AS1 | Panobinostat | DB06603 | Nephroblastoma | 26176219 | approved |
| LHFPL3-AS2 | Oxaliplatin | DB00526 | Gastric Cancer | 29156779 | approved |
| LHFPL3-AS2 | Panobinostat | DB06603 | Nephroblastoma | 26176219 | approved |
| LINC01612 | Oxaliplatin | DB00526 | Gastric Cancer | 29156779 | approved |
| SFTA1P | Panobinostat | DB06603 | Nephroblastoma | 26176219 | approved |
| LINC02688 | Panobinostat | DB06603 | Nephroblastoma | 26176219 | approved |
NA: not available.